You are here

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Pittsburgh, Pennsylvania, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-50 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diabetes mellitus Type 1

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Asthma, COPD

- Smoking

NCT00287066
Pfizer
Terminated
A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Type 2 Diabetes Mellitus
NCT01396161
All Genders
18+
Years
Multiple Sites
Type 2 Diabetes Mellitus
NCT00886821
All Genders
18+
Years
Multiple Sites
Type 2 Diabetes Mellitus, NIDDM
NCT01272804
All Genders
18+
Years
Multiple Sites
Type 2 Diabetes Mellitus
NCT00246623
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now